TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Dermacell AB
Closing information (x1000 SEK)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
3,888
|
3,289
|
2,947 |
| Financial expenses |
23
|
4
|
11 |
| Earnings before taxes |
53
|
-171
|
12 |
| EBITDA |
113
|
-129
|
64 |
| Total assets |
1,033
|
706
|
778 |
| Current assets |
1,016
|
649
|
681 |
| Current liabilities |
658
|
249
|
136 |
| Equity capital |
202
|
453
|
592 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
5
|
5
|
4 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
19.6%
|
64.2%
|
76.1% |
| Turnover per employee |
778
|
658
|
737 |
| Profit as a percentage of turnover |
1.4%
|
-5.2%
|
0.4% |
| Return on assets (ROA) |
7.4%
|
-23.7%
|
3.0% |
| Current ratio |
154.4%
|
260.6%
|
500.7% |
| Return on equity (ROE) |
26.2%
|
-37.7%
|
2.0% |
| Change turnover |
599
|
342
|
377 |
| Change turnover % |
18%
|
12%
|
15% |
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % |
0%
|
25%
|
0% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.